Spinal shot before robotic hysterectomy may ease Post-Op pain
NCT ID NCT07169604
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study looked at whether giving a spinal painkiller (morphine) before robotic hysterectomy helps reduce pain after surgery. Researchers reviewed records from 100 patients who had the procedure. The main goal was to see if this approach lowers pain scores, which could lead to a smoother recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- intrathecal morphine (a spinal painkiller)
- What this could lead to
- If it works, this could point toward a better way to manage pain after robotic hysterectomy, possibly reducing the need for other pain medicines.
- What could go wrong
- This is a small, retrospective study, so results may not apply to everyone. Spinal injections also carry risks like headache or rare infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
100 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients with gynaecological malignant or benign condition needed for hysterectomy
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: patients scheduled for robotic hysterectomy acceptation of written informed consent Exclusion Criteria: were contraindications to neuraxial anesthesia (such as coagulopathies, platelet count below 100,000/mm³ or thrombocytopathy), severe valvular heart disease, left ventricular ejection fraction less than 35%, history of obstructive or restrictive pulmonary disease, or significant neurological disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pain management are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fondazione Policlinico Universitario Policlinico Gemelli
Roma, RM, 00166, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug tested to curb pain after liver surgery
- Two simple tweaks may cut pain after appendix surgery
- Nerve blocks put to the test for chest tube pain
- Hyaluronic acid gel vs standard paste: which calms infected root canals better?
- Cooling spray takes aim at the sting of an IV
- Heat may boost numbing power of lidocaine for eye shots